Clinical Trials Browser

Phase 2/3 × Vorinostat × Thoracic × Clear all

NCT00473889 2015-07-03

A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)

Phase 2/3 Terminated

253 enrolled 13 charts

Stage IIIB or IV Non-Small Cell Lung Cancer